Peginesatide
id:
peginesatide-274-17224765
title:
Peginesatide
text:
Peginesatide, developed by Affymax and Takeda, is an erythropoietic agent, a functional analog of erythropoietin. It was approved by the U.S. Food and Drug Administration for treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis. On February 23, 2013, Affymax and Takeda issued a press release indicating that they were recalling all batches of peginesatide from the market. On June 16, 2014, Affymax and Takeda issued a press release stating that Takeda will
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Peginesatide
date created:
date modified:
2023-12-31T23:36:15Z
main entity:
{"identifier":"Q3662569","url":"https://www.wikidata.org/entity/Q3662569"}
image:
fields total:
13
integrity:
14